The Evidence Multiple large cardiovascular outcome trials have demonstrated GLP-1 medications reduce heart attacks, strokes, and cardiovascular death: SUSTAIN-6 (semaglutide): 26% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk
declared he will soon direct the FDA to remove at least 14 peptides from a compounding ban list, allowing them to be produced by these specialty pharmacies (this list does not include any GLP-1s)
10.1016/j.neuint.2020.104707 2 BaeH.-D.KimM.LeeJ.LeeK
Pairing with resistance training and calcium/vitamin D is critical
The gossip in the hallways of the University was that a new drug was in the pipeline, called Virginiamycin, which was an antibiotic used to treat these cases
Proper Documentation and Storage Protocols Proper packaging includes for research use only, not for human or veterinary consumption, lot number, and storage conditions on the vial or outer packaging